In this open discussion webinar, we talk to the experts in DNA sequencing and DNA from saliva about what’s trending in whole genome sequencing (WGS). Joshua Burgess, Manager of Research and Development at Illumina, and Rafal Iwasiow, Vice President of Research and Development at DNA Genotek, will discuss why human genomic research is moving towards WGS and what this means for research study design and planning. They will also look at the viability of saliva as a DNA sample source, as compared to blood, for whole genome sequencing using Illumina’s Nextera DNA Flex to produce high quality libraries for WGS. The discussion will follow with open Q&A from attendees.

Joshua Burgess is a Manager of Scientific Research in Research and Development and has worked for Illumina for 5 years. Joshua obtained his Ph.D. from Mayo Graduate School in Rochester, MN and conducted a post-doctoral fellowship at the University of North Carolina-Chapel Hill.

You may have seen him already on The Genome Spot!  Dr. Iwasiow is the Vice President of Research and Development and has worked in numerous roles for DNA Genotek since 2006. Under Dr. Iwasiow’s leadership, the Research and Development team contributed to the successful 510(k) FDA clearances of the Oragene•Dx saliva collection device, as well as developed and delivered new chemistries, products and service offerings throughout his years with the company. Prior to joining DNA Genotek, Dr. Iwasiow completed a post-doctoral fellowship at the National Research Council of Canada and he holds a Ph.D. degree in Cellular and Molecular Medicine from the University of Ottawa.

 

Register/Log On

 

When: Thursday, June 21st, 2018
Time: 9:00am PDT/ 12:00pm EDT/ 5:00pm BST
The webinar will be available on-demand after this date. 

 

 

Joshua Burgess, Ph.D, Manager, Scientific Research, Research and Development, Illumina

 

 

 

 

 

 

 

 

Rafal Iwasiow, Ph.D, Vice President, Research and Development, DNA Genotek Inc